has been cited by the following article(s):
|
[1]
|
T-regulatory cells and their clinico-pathological correlation in pediatric B-cell acute lymphoblastic leukemia: An observational study
Journal of Laboratory Physicians,
2026
DOI:10.25259/JLP_381_2025
|
|
|
|
|
[2]
|
Treatment-Related Toxicity Profile in Children with Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma during Induction Chemotherapy: Prospective Insights from a South Indian Cohort
Indian Journal of Medical and Paediatric Oncology,
2025
DOI:10.1055/s-0045-1811561
|
|
|
|
|
[3]
|
Assessment of hematological toxicity and risk stratification in children aged 1-12 years with acute lymphoblastic leukemia receiving ALL COG protocol: a prospective observational study from a tertiary care center in central India
International Journal of Contemporary Pediatrics,
2025
DOI:10.18203/2349-3291.ijcp20253780
|
|
|
|
|
[4]
|
Leukaemia - Recent Advances in Diagnosis and Therapeutic Modalities
Oncology,
2025
DOI:10.5772/intechopen.1013253
|
|
|
|
|
[5]
|
Clinical use of polyvalent intravenous immunoglobulins during intensive polychemotherapy in children with acute lymphoblastic leukemia
Minerva Pediatrics,
2023
DOI:10.23736/S2724-5276.19.05494-X
|
|
|
|
|
[6]
|
The Role of SLC22A1 and Genomic Ancestry on Toxicity during Treatment in Children with Acute Lymphoblastic Leukemia of the Amazon Region
Genes,
2022
DOI:10.3390/genes13040610
|
|
|
|